Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Mindray Medical International Ltd (ADR) Company Profile (NYSE:MR)

Consensus Ratings for Mindray Medical International Ltd (ADR) (NYSE:MR) (?)
Ratings Breakdown: 6 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $34.05 (17.25% upside)

Current Analysts' Coverage Summary for Mindray Medical International Ltd (ADR) (NYSE:MR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/22/2014ZacksReiterated RatingNeutral -> Neutral$31.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014Jefferies GroupLower Price TargetHold$36.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Morgan StanleyReiterated RatingIn-LineViewTweet This Rating  Share This Rating on StockTwits
4/24/2014Credit SuisseUpgradeUnderperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/7/2014Goldman SachsDowngradeBuy -> Neutral$45.50 -> $31.20ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014OppenheimerLower Price TargetOutperform$50.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
7/3/2013Piper JaffrayDowngradeOverweight -> Neutral$40.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2013HSBCDowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Credit AgricoleDowngradeOutperform -> Neutral$34.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/23/2012 forward)
Discuss Mindray Medical International Ltd (ADR)